Sensationalistic journalism and tales of snakebite: are rattlesnakes rapidly evolving more toxic venom?

@article{Hayes2010SensationalisticJA,
  title={Sensationalistic journalism and tales of snakebite: are rattlesnakes rapidly evolving more toxic venom?},
  author={W. Hayes and S. Mackessy},
  journal={Wilderness & environmental medicine},
  year={2010},
  volume={21 1},
  pages={
          35-45
        }
}
  • W. Hayes, S. Mackessy
  • Published 2010
  • Medicine
  • Wilderness & environmental medicine
  • Recent reports in the lay press have suggested that bites by rattlesnakes in the last several years have been more severe than those in the past. The explanation, often citing physicians, is that rattlesnakes are evolving more toxic venom, perhaps in response to anthropogenic causes. We suggest that other explanations are more parsimonious, including factors dependent on the snake and factors associated with the bite victim's response to envenomation. Although bites could become more severe… CONTINUE READING
    26 Citations
    An Analysis of Media-Reported Venomous Snakebites in the United States, 2011-2013.
    • 7
    Neurological effects of venomous bites and stings: snakes, spiders, and scorpions.
    • 13
    Mojave toxin-type ascending flaccid paralysis after an envenomation by a Southern Pacific Rattlesnake in a dog.
    • 7
    Epidemiology of fatal snakebites in the United States 1989-2018.
    Defensive stinging by Parabuthus transvaalicus scorpions: risk assessment and venom metering
    • 42
    • PDF
    Arizona Ridge‐nosed rattlesnake envenomation: Case report of a personal encounter with the official state reptile of Arizona, Crotalus willardi willardi

    References

    SHOWING 1-10 OF 117 REFERENCES
    Treatment of US Crotalidae Bites
    • 8
    The legitimacy of rattlesnake bites in central Arizona.
    • 31
    Denim clothing reduces venom expenditure by rattlesnakes striking defensively at model human limbs.
    • 11
    • PDF
    Association of rattlesnake bite location with severity of clinical manifestations.
    • 17